IONS IONIS PHARMACEUTICALS INC Investments/Divestments 8-K Filing 2023 - Agreement with Roche for RNA-targeting investigational medicines Ionis Pharmaceuticals, Inc. has entered into an agreement with Roche for two early-stage programs for RNA-targeting investigational medicines for the treatment of Alzheimer's disease and Huntington's disease.Get access to all SEC 8-K filings of the IONIS PHARMACEUTICALS INC